Clinical Trial Details

Overview

Research Study Summary

A Randomized, Double-Blind, Placebo-Controlled Parallel Arm Study to Evaluate the Safety, Tolerability, and Effect on Atrial Fibrillation Burden of BMS-919373 in Patients with Paroxysmal Atrial Fibrillation

Purpose

The primary purpose of this study is to to assess, by the use of long term non-invasive beat-to-beat monitoring system, the effect of BMS-919373 on the percent change from baseline relative to placebo of atrial fibrillation burden in subjects with paroxysmal atrial fibrillation.

To Learn more

CW ID: 206090
Date Last Changed: March 12, 2015

Clinical Trial Snapshot

Phase
2
Gender
Both Male and Female
Age
18 to 75 Years
Overall Status
Recruiting
Lead Sponsor
Bristol-Myers Squibb
Duration
3 Months
Facility Type
Out-Patient
Compensation
Up to $150

Eligibility

Inclusion Criteria:

  • Paroxysmal Atrial Fibrillation with documented AF within 6 months prior to screening
  • Able to tolerate withdrawal of antiarrhythmic therapy (rhythm control)

Exclusion Criteria:

  • Permanent or persistent Atrial Fibrillation
  • Cardioversion within 3 months of study drug administration
  • Any history of TIA or stroke
  • Heart failure of NYHA class III or greater (symptoms of heart failure at rest or with minimal exertion)
  • Heart failure of NYHA class II (symptoms of heart failure with routine levels of exertion)
  • Valvular heart disease (including any valvular insufficiency or stenosis greater than "mild")

More Info

Study related care is provided at no cost. You may also be compensated for time and travel.

Contact

Cheryl Nickles, Patient Recruitment Coordinator
Chase Medical Research, LLC
500 Chase Parkway, 3rd Floor
Waterbury, CT 06708
Phone: (203) 419-4404
Fax: (203) 465-7924

View Map

Research Center Information:

Chase Medical Research, LLC

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.